Although the biodesign innovation process may appear to be relatively straightforward and linear, in reality it is complex,
iterative, and dynamic. The innovator faces a continual stream of interconnected challenges and opportunities as s/he moves
from needs finding to integration, and then on to commercial launch. New information becomes available at every stage of the
process, which can require the innovator to revisit previous decisions, address new risks, and consider complicated trade-offs.
Moreover, the biodesign innovation process takes place within the competitive medtech field, against the backdrop of the increasingly
demanding and complicated domestic and global healthcare environment.
Nothing demonstrates ...